Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The Residential Real Estate Crash Index -- Ignore unavailable to you. Want to Upgrade?

To: Lizzie Tudor who wrote (181262)	2/2/2009 4:54:22 PM
From: MulhollandDrive	Respond to of 306849

The woman is a whack obviously and needs medical care for mental illness it sounds like to me but why the outrage about medical costs? sigh... the outrage is over the fact that the cost to facilitate her baby obsession is NOT the responsibility of the taxpayer OR medical insurers....CA MANDATES that fertility procedures in the state be covered by insurers... if an insurer chooses to offer this type of coverage, i really don't care, that's a private business decision that is within their purview ....once it is mandated ALL insurers are required by law to provide this coverage and the rest of the insured pool pays for it i don't want to be paying for some mental chick to have her brood either with taxpayer dollars OR higher medical insurance costs, this kind of BS has to stop in this economic environment....we don't have the money for this kind of insanity click on the link and listen to karl next hour (good conversation going right now about good bank/bad bank)

To: Lizzie Tudor who wrote (181262)	2/2/2009 8:25:51 PM
From: pheilman_	Read Replies (1) \| Respond to of 306849

OT Bexxar from GlaxoSmithKline and Zevalin from Biogen Idec. The drugs are approved as a third-line treatment for non-Hodgkin's lymphoma, a form of cancer that begins in the lymph system, after other treatments have failed. But they are sometimes administered as a first line of attack, a use that is not approved. The medications cost $22,210 for a single dose, which constitutes a full course of treatment, according to spokeswomen for both companies. … lymphomation.org Having seen a relative go through the modern, conventional treatment for non-Hodkin's lymphoma, yes, everytime. Use the best, new treatment. Al spent one year in treatment, 12 weeks in the hospital. And contracted a serious infection during the course. Assuming $400 per day in the hospital the conventional treatment ran $34K just for the bed. So, yeah, one shot, one week sounds real good. Anytime you spend time in the hospital the risk of unpleasant problems skyrockets. Given the choice of one shot or one year, which would you pick? On topic, um, they own a house in LA?